A biomedical treatment for severe depression in which a brief electrical current is sent through the brain of an anesthetized patient is Electroconvulsive Therapy (ECT).
What is depression?
- A serious medical illness that commonly has an impact on a person's feelings, thoughts, and behaviors is known as major depressive disorder, also referred to as depression.
- Depression is characterized by sadness and/or a loss of interest in former pastimes.
What is Electroconvulsive Therapy?
- Electroconvulsive therapy (ECT) is a procedure that uses small electric currents on purpose to send the brain into a brief seizure while the patient is under general anesthesia.
- ECT appears to alter brain chemistry in a way that swiftly alleviates the signs and symptoms of several mental health problems.
- When other therapies have failed and the entire course of treatment has been completed, ECT frequently helps, but not always.
Learn more about the Electroconvulsive Therapy with the help of the given link:
brainly.com/question/26927084
#SPJ4
Answer:
b
Explanation:
he is developing before it happens
Answer: They say that you can't teach an old dog new tricks, but when it comes to the brain, scientists have discovered that this old adage simply isn't true. The human brain has an astonishing ability to adapt and change even into old age. This ability is known as neuroplasticity. With the right stimulation.
Explanation:
Answer:
The answer is A true
Explanation:
The glial cells are responsible for conducting the information that comes out of the neurons, they also play the main role of support and nutrition of the neurons.
Answer:
The arguments for the Compassionate Use Act include the following:
1. The patient has an acute disease or health condition. Also, whose life is being threaten.
2. The patient is not allowed to enter a clinical trial.
3. The patient benefit supports the potential risks of treatment.
4. The patient has no other treatment therapy for the disease or health condition
5. The investigative outcome of the treatment should not interfere with any trials that could support a medical's product development or marketing approval for the treatment indicated.
Explanation:
